​
​

Iterum Therapeutics Ownership | Who Owns Iterum Therapeutics?

OverviewRevenueFinancialsChartTranscripts

Iterum Therapeutics Ownership Summary

1.81% insiders, and 98.19% retail investors. Blue bell private wealth management is the largest institutional shareholder, holding 0.00% of ITRM shares. AMOne Fisher US Micro Equity Fund is the top mutual fund, with 0.16% of its assets in Iterum Therapeutics shares.

ITRM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockIterum Therapeutics-1.81%98.19%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryBiotech Stocks 44.85%7.67%47.48%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blue bell private wealth management66.000.00%$76.00
Ancora advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue bell private wealth management66.00-$76.00
Ancora advisors---

Top Buyers

HolderShares% AssetsChange
Blue bell private wealth management66.00--
Ancora advisors---38.00

Top Sellers

HolderShares% AssetsChange
Ancora advisors---38.00
Blue bell private wealth management66.00--

Sold Out

HolderChange
Ancora advisors-38.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-50.00%66-36.54%-67750.00%--100.00%--
Mar 31, 20242-104--123662.50%1---
Dec 31, 20232-104--124075.00%----
Sep 30, 20232-104--122475.00%----
Jun 30, 20232-104--125000.00%--100.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
AMOne Fisher US Micro Equity Fund35.22K0.16%35.22K
Fidelity Nasdaq Composite Index12.37K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 22, 2023Dunne Michael W.-Buy$35.00K
Dec 18, 2023Dunne Michael W.-Buy$18.44K
Nov 22, 2023Dunne Michael W.-Buy$40.69K
Nov 20, 2023Fishman Corey N. Chief Executive OfficerBuy$15.86K
Dec 02, 2022Puttagunta Sailaja Chief Medical OfficerSell$4.44K

Insider Transactions Trends

DateBuySell
2023 Q43-
2023 Q3--
2023 Q2--
2023 Q1--
2022 Q4-1

ITRM Ownership FAQ

Who Owns Iterum Therapeutics?

Iterum Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 1.81% insiders and 98.19% retail investors. The average institutional ownership in Iterum Therapeutics's industry, Biotech Stocks , is 44.85%, which Iterum Therapeutics falls below.

Does Blackrock own Iterum Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Iterum Therapeutics.

Who is Iterum Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue bell private wealth management is Iterum Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 66 Iterum Therapeutics shares, valued at 76$.

Who is the top mutual fund holder of Iterum Therapeutics shares?

AMOne Fisher US Micro Equity Fund is the top mutual fund holder of Iterum Therapeutics shares, with 0.16% of its total shares outstanding invested in 35.22K Iterum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools